2008-11-09 05:35:01 -
- BioScrip, Inc. (Nasdaq: BIOS) today announced that it will present at the forthcoming 17th Annual Credit Suisse Health Care Conference, to be held November 11-14, 2008, at the Arizona Biltmore Resort in Phoenix, Arizona.
BioScrip's Chairman and Chief Executive Officer, Richard H. Friedman, and Stanley G. Rosenbaum, Executive Vice President and Chief Financial Officer will present Wednesday, November
12th at 2:30 p.m. MST (Mountain Standard Time; 4:30 p.m. Eastern Standard Time).
Investors may access the live audio web cast of BioScrip's presentation at the following link:
w.on24.com/r.htm?e=125762&s=1&k=8908FC153C814F7C8D65E27 B4174CFA4. (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.) The web cast replay of the presentation may also be accessed via BioScrip's website at www.bioscrip.com under the Investors section.
About BioScrip, Inc.
BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payors and pharmaceutical manufacturers to provide access to medications and management solutions to optimize outcomes for chronic and other complex healthcare conditions.
Forward Looking Statements
This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company and our success with respect to the integration and consolidation. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.
In-Site Communications, Inc.
Lisa M. Wilson, 917-543-9932
lwilson@insitecony.com 
